Atlas Trials

Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome

Clinical trial NCT02904967 · COMPLETED

Trial details

NCT number
NCT02904967
Sponsor
Assistance Publique Hopitaux De Marseille
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Venous Thromboembolism
Start date
2013-01-18
Primary completion
2016-07-18
Enrollment
221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.